Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

H.C. Leffers; Mikkel Østergaard; Bente Glintborg; N.S. Krogh; U. Tarp; T. Lorenzen; Annette Hansen; M.S. Hansen; L. Dreyer; M.S. Jakobsen; Merete Lund Hetland

Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

H.C. Leffers, Mikkel Østergaard, Bente Glintborg, N.S. Krogh, U. Tarp, T. Lorenzen, Annette Hansen, M.S. Hansen, L. Dreyer, M.S. Jakobsen, Merete Lund Hetland

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	64
Udgave nummer	10 suppl.
Sider (fra-til)	S543
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2012

Adgang til dokumentet

http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991

Citationsformater

Leffers, H. C., Østergaard, M., Glintborg, B., Krogh, N. S., Tarp, U., Lorenzen, T., Hansen, A., Hansen, M. S., Dreyer, L., Jakobsen, M. S., & Hetland, M. L. (2012). Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry. Arthritis & Rheumatism, 64(10 suppl.), S543. http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991

Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry. / Leffers, H.C.; Østergaard, Mikkel; Glintborg, Bente et al.

I: Arthritis & Rheumatism, Bind 64, Nr. 10 suppl., 2012, s. S543.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Leffers, HC, Østergaard, M, Glintborg, B, Krogh, NS, Tarp, U, Lorenzen, T, Hansen, A, Hansen, MS, Dreyer, L, Jakobsen, MS & Hetland, ML 2012, 'Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.', Arthritis & Rheumatism, bind 64, nr. 10 suppl., s. S543. <http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991>

@article{1e97b3c0473c4b519f9efe62534826a1,

title = "Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.",

author = "H.C. Leffers and Mikkel {\O}stergaard and Bente Glintborg and N.S. Krogh and U. Tarp and T. Lorenzen and Annette Hansen and M.S. Hansen and L. Dreyer and M.S. Jakobsen and Hetland, {Merete Lund}",

year = "2012",

language = "English",

volume = "64",

pages = "S543",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 suppl.",

}

TY - ABST

T1 - Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

AU - Leffers, H.C.

AU - Østergaard, Mikkel

AU - Glintborg, Bente

AU - Krogh, N.S.

AU - Tarp, U.

AU - Lorenzen, T.

AU - Hansen, Annette

AU - Hansen, M.S.

AU - Dreyer, L.

AU - Jakobsen, M.S.

AU - Hetland, Merete Lund

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 2326-5205

VL - 64

SP - S543

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 suppl.

ER -